Voyager Therapeutics (VYGR) Preferred Stock Liabilities (2014 - 2016)

Voyager Therapeutics (VYGR) has 3 years of Preferred Stock Liabilities data on file, last reported at $36.1 million in Q4 2016.

• For the quarter ending Q4 2016, Preferred Stock Liabilities changed 0.13% year-over-year to $36.1 million; the trailing twelve-month figure through Dec 2016 stood at $36.1 million (changed 0.13% YoY), and the FY2016 full-year result was $36.1 million, changed 0.13% from the prior year.
• Preferred Stock Liabilities was little changed at $36.1 million in Q4 2016, from $36.1 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $89.0 million in Q3 2015 to a low of $22.0 million in Q4 2014.
• A 3-year average of $45.8 million and a median of $36.1 million in 2015 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities surged 64.04% in 2015 and grew 0.13% in 2016, its largest moves.
• Tracing VYGR's Preferred Stock Liabilities over 3 years: stood at $22.0 million in 2014, then jumped by 64.04% to $36.1 million in 2015, then advanced by 0.13% to $36.1 million in 2016.
• Business Quant data shows VYGR's Preferred Stock Liabilities at $36.1 million in Q4 2016, $36.1 million in Q4 2015, and $89.0 million in Q3 2015.